ArticleScience advances2021
Inducing thermodynamically blocked atomic ordering via strongly driven nonequilibrium kinetics.
Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Targeting O-GlcNAcylation: Novel Therapeutic Strategies for Neurological Disease.Molecular neurobiology · 2025Review
- Surface-plasmon control of ultrafast energy-relaxation modes in photoexcited Au nanorods probed by time-resolved single-particle X-ray imaging.Nature communications · 2025Article
- Anti-inflammatory interventions in coronary artery disease: antipodal responses requiring targeted therapeutic strategies.Basic research in cardiology · 2025Review
- Development of the Nanobeam X-ray Experiments instrument at PAL-XFEL.Journal of synchrotron radiation · 2025Article
- Time-resolved probing of laser-induced nanostructuring processes in liquids.Beilstein journal of nanotechnology · 2025Review
- Inverted nucleation for photoinduced nonequilibrium melting.Science advances · 2024Article
- Development of the multiplex imaging chamber at PAL-XFEL.Journal of synchrotron radiation · 2024Article
- Necroptosis inhibitors: mechanisms of action and therapeutic potential.Apoptosis : an international journal on programmed cell death · 2024Review
- Observing femtosecond orbital dynamics in ultrafast Ge melting with time-resolved resonant X-ray scattering.IUCrJ · 2023Article
- Single-pulse characterization of the focal spot size of X-ray free-electron lasers using coherent diffraction imaging.Journal of synchrotron radiation · 2023Article
- Three-dimensional femtosecond snapshots of isolated faceted nanostructures.Science advances · 2023Article
- Pump-probe capabilities at the SPB/SFX instrument of the European XFEL.Journal of synchrotron radiation · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ultrafast light-matter interactions enable inducing exotic material phases by promoting access to kinetic processes blocked in equilibrium. Despite potential opportunities, actively using nonequilibrium kinetics for material discovery is limited by the poor understanding on intermediate states of driven systems. Here, using single-pulse time-resolved imaging with x-ray free-electron lasers, we found intermediate states of photoexcited bismuth nanoparticles that showed kinetically reversed surface ordering during ultrafast melting. This entropy-lowering reaction was further investigated by molecular dynamics simulations to reveal that observed kinetics were thermodynamically buried in equilibrium, which emphasized the critical role of electron-mediated ultrafast free-energy modification in inducing exotic material phases. This study demonstrated that ultrafast photoexcitations of electrons provide an efficient strategy to induce hidden material phases by overcoming thermodynamic barriers via nonequilibrium reaction pathways.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.